Ozempic vs Wegovy: Same Drug, Different Goals
Both injections contain semaglutide, but Ozempic is dosed for type 2 diabetes and Wegovy for chronic weight management. The right pick depends on your health history, insurance coverage, and how much weight you aim to lose.
Ozempic and Wegovy are two brand-name versions of semaglutide, a once-weekly GLP-1 receptor agonist that lowers appetite, slows stomach emptying and improves blood sugar. Ozempic is FDA-approved to treat type 2 diabetes (and to lower cardiovascular risk in those patients) at doses up to 2 mg weekly, while Wegovy is FDA-approved for chronic weight management and heart-risk reduction in adults with obesity at doses up to 2.4 mg (and newly 7.2 mg) weekly. Because they carry different maximum doses, indications and insurance rules, your prescriber must choose the version that legally matches your diagnosis and weight-loss goals.
- Ozempic is approved for type 2 diabetes and cardiovascular risk reduction at 0.5 mg, 1 mg and 2 mg weekly doses. (accessdata.fda.gov)
- Wegovy is approved for chronic weight management and to reduce serious heart problems in adults with obesity at 2.4 mg and, since March 2026, 7.2 mg weekly maintenance doses. (fda.gov)
- In the STEP 1 trial, Wegovy 2.4 mg led to 14.9 % average weight loss in 68 weeks, versus 4-7 kg loss typically seen with Ozempic’s diabetes doses. (nejm.org)
- The 2026 list prices are about $1,027 for Ozempic and $1,349 for Wegovy, but Novo Nordisk has pledged to drop both to $675 in 2027. (bloomberg.com)
- Most commercial plans cover Ozempic for diabetes, but only 1 in 4 cover Wegovy for weight loss; Medicare began limited Wegovy coverage in July 2026. (novonordisk-us.com)
Is Ozempic the Same as Wegovy?
Semaglutide is the active molecule in both products, but each brand comes in its own delivery pen, dose range and FDA-labeled use. The drug formula, half-life (about one week) and mechanism are identical. What changes is the concentration per pen and the highest dose studied and approved for a specific population.
Key distinction: Pharmacies must dispense exactly what the prescription specifies. A pharmacist cannot substitute Wegovy for Ozempic the way they might swap a generic for a brand, because the NDC codes and labeled indications differ.
How Their FDA Approvals Differ
Ozempic’s first approval (December 2017) was for glycemic control in type 2 diabetes; a 2020 label update added proven cardiovascular benefit. Wegovy’s initial 2021 approval covered adults with obesity or overweight plus one comorbidity, and in March 2024 the FDA expanded that label to include reduction of heart-attack, stroke and CV death risk.
The agency also cleared a high-dose Wegovy (7.2 mg weekly) in March 2026 for patients who plateau on 2.4 mg. (fda.gov)
| Product | Initial FDA approval | Max maintenance dose | Main labeled indication |
|---|---|---|---|
| Ozempic semaglutide | Dec 5 2017 | 2 mg weekly | Type 2 diabetes, CV risk reduction |
| Wegovy semaglutide | June 4 2021 | 2.4 mg (adult); 7.2 mg (select adults 2026) | Chronic weight management, CV risk reduction in obesity |
Dose and Pen Differences
Both drugs start at 0.25 mg weekly and increase every 4-5 weeks, but the target doses diverge. Wegovy escalates to 2.4 mg (or 7.2 mg for the new high-dose pen), whereas Ozempic usually tops out at 1 mg or 2 mg.
| Step | Ozempic weekly dose | Wegovy weekly dose |
|---|---|---|
| Starter | 0.25 mg (4 weeks) | 0.25 mg (4 weeks) |
| Step 2 | 0.5 mg (≥4 weeks) | 0.5 mg (4 weeks) |
| Step 3 | 1 mg (optional maintenance) | 1 mg (4 weeks) |
| Step 4 | 2 mg (max) | 1.7 mg (4 weeks) |
| Step 5 | N/A | 2.4 mg (standard max) |
| Optional | N/A | 7.2 mg (select patients 2026) |
Pen formats: Ozempic pens are multi-dose with dose selectors, while most Wegovy pens are single-dose, color-coded and pre-set. The high-dose Wegovy FlexTouch uses the adjustable mechanism familiar from insulin pens.
How Much Weight (or A1C) Can You Expect?
Wegovy’s higher dose produces roughly three times the weight loss seen with Ozempic’s diabetes doses. In STEP 1, adults without diabetes lost an average 14.9 % of body weight with Wegovy 2.4 mg at week 68. (nejm.org) Patients using Ozempic 1 mg for diabetes typically lose 4–7 kg in the same timeframe across SUSTAIN trials. (pmc.ncbi.nlm.nih.gov)
💡 Why bigger isn’t always better
Higher doses raise the odds of nausea and vomiting. If you have modest weight-loss goals (5–7 %), your clinician may aim for Ozempic-level doses even when Wegovy is prescribed.
Blood sugar impact: Ozempic 1 mg lowers A1C around 1.5 % from baseline. (pmc.ncbi.nlm.nih.gov) Wegovy is not marketed for diabetes control, but STEP 2 showed it still dropped A1C by 1.2 % in participants with type 2 diabetes. (pmc.ncbi.nlm.nih.gov)
Ready to start a GLP-1 plan?
Connect with a licensed provider online and see if semaglutide is right for you.
Are Side Effects the Same?
Yes-because the molecule is identical, the side-effect profile overlaps. The difference is frequency: higher Wegovy doses mean more nausea, diarrhea and constipation.
Gastrointestinal symptoms: Nausea (up to 44 % with 2.4 mg) is dose-dependent.Gallbladder issues: Semaglutide slightly raises cholelithiasis risk. (accessdata.fda.gov)
Cardiovascular benefits: Both labels now include proven CV risk reduction in appropriate populations. (fda.gov)
See our semaglutide side-effects guide for practical nausea hacks.
Trying to decide between Ozempic and Wegovy?
Check the column that fits your situation:
✅ Ozempic may be enough
- You have diagnosed type 2 diabetes
- Insurance covers diabetes drugs but not weight-loss drugs
- Goal weight loss is under 10 %
- You prefer a dial-a-dose pen
🏥 Wegovy may be indicated
- BMI ≥30 kg/m² or ≥27 kg/m² with comorbidity
- Need to lose more than 10 % body weight
- You do not have diabetes or A1C is already at goal
- You qualify for new CV risk-reduction label
Coverage and Cost: What You’ll Pay in 2026
List prices reflect manufacturer quotes, not what patients actually pay. Copays, coupons, and formularies can shrink the bill dramatically-or leave you paying cash.
| Drug | 2026 list price (4-week pen) | Typical Rx.com coupon price | % of commercial plans covering |
|---|---|---|---|
| Ozempic | $1,027.51 | $199–$349 | ≈ 85 % |
| Wegovy | $1,349.02 | $249–$399 | ≈ 25 % |
Use Rx.com to compare prices-most patients pay well under list with a free discount card.
⚠️ Medicare update
Since July 1 2026, Wegovy is covered for eligible Medicare beneficiaries with obesity and heart disease under the GLP-1 Bridge program, but prior authorization applies. (novonordisk-us.com)
Why Some Doctors Prescribe Ozempic for Weight Loss
Using Ozempic purely for weight management is considered off-label, but it happens when insurers refuse Wegovy. Prescribers must document a diabetes diagnosis (or prediabetes) to meet coverage criteria, leaving many patients paying cash.
If you need Wegovy-level doses for obesity, discuss the legal and ethical implications of off-label Ozempic. Switching mid-therapy can lead to supply shortages and dosing confusion-see our Ozempic weight-loss dosing guide for details.
How to Decide Which Version of Semaglutide Is Right for You
Match the drug to the diagnosis, dose to the goal, and insurance to your wallet. Bring a recent A1C, BMI and medication list to your appointment so your clinician can justify the prescription.
- If you have diabetes: Ozempic usually satisfies both glucose and modest weight goals.
- If you have obesity without diabetes: Wegovy’s higher dose is more effective and legally on-label.
- If cost is the barrier: Ask about manufacturer savings cards, 340B clinics or future generic versions (expected 2032).
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Severe or persistent vomiting - may signal pancreatitis.
- Sudden belly pain, fever or jaundice - could be gallstones.
- Rapid heartbeat or dizziness - risk of dehydration or low blood pressure.
- Changes in vision - possible diabetic retinopathy worsening.
- A lump in the neck - report thyroid swelling right away.
- Thoughts of self-harm - call or text 988 if you feel unsafe.
- Allergic reaction - hives, swelling of face or throat, trouble breathing.
- Signs of kidney problems - little or no urine, swelling in feet.
Scientific References
- U.S. FDA. Ozempic (semaglutide) injection prescribing information. Updated 2022.
- U.S. FDA. Wegovy (semaglutide) injection prescribing information. Updated 2023.
- FDA Press Release. Wegovy approved to reduce risk of serious heart problems in adults with obesity or overweight. March 8 2024.
- FDA Press Release. FDA approves higher-dose Wegovy (7.2 mg). March 2026.
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
- Pratley R et al. Comparative effectiveness of long-acting GLP-1 receptor agonists. Diabetes Ther. 2020;11:121-140.
- Bloomberg News. Generic Ozempic could cost less than $3 a month, but list price is $1,027. March 6 2026.
Frequently Asked Questions
Can I switch from Ozempic to Wegovy without restarting the dose escalation?
Usually yes if you move to an equivalent or lower dose, but your prescriber may repeat a step to minimize side effects. Transition plans are covered in our GLP-1 beginner’s guide.
Is Wegovy stronger than Ozempic?
Per milligram, the drug is identical. Wegovy’s efficacy comes from its higher approved maintenance dose (2.4 mg versus 2 mg) and newly 7.2 mg option.
Will Medicare pay for Wegovy now?
As of July 2026, Medicare covers Wegovy for beneficiaries with obesity and established cardiovascular disease under the GLP-1 Bridge program, but prior authorization and step therapy apply.
What happens if my insurance covers Ozempic but I want Wegovy?
You can pay cash, appeal the denial, or discuss off-label Ozempic. Each choice has legal and financial trade-offs outlined above.
Do Ozempic and Wegovy taste or feel different when injected?
No-the fluid is the same. The Wegovy single-dose pens deliver the shot automatically, while Ozempic requires dialing a dose and pressing the plunger.
Can I use compounded semaglutide instead?
Compounded versions are legal only when the branded drugs are in shortage. Potency and supply can vary; see our compounded semaglutide overview.
How long before I see weight-loss results?
Most people notice appetite suppression within two weeks. Clinically significant weight changes usually appear after 4–8 weeks and build through 6 months.